Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Advanced Parenting Education in Pediatrics: The APEP Project
This study will evaluate the effectiveness of a parent training program in improving parenting skills and reducing behavioral symptoms in young children who are at risk for developing childhood behavior disorders.
Attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) are
common childhood behavior disorders. Children with ADHD experience hyperactivity,
distractibility, poor concentration, and impulsivity. If left untreated, ADHD can continue
into adulthood, and can cause problems in family, social, and work environments. Children
with ODD exhibit an ongoing pattern of uncooperative, defiant, and hostile behavior toward
authority figures. Symptoms of ODD, including frequent temper tantrums, anger, resentment,
and vindictiveness, may interfere with a child's everyday functioning. The Incredible Years
parent training program has been shown to be effective in multiple settings at training
parents to manage their child's behavior. This study will evaluate the effectiveness of the
Incredible Years training program within a pediatric office setting at improving parenting
skills and reducing behavioral symptoms in young children who are at risk for developing
childhood behavior disorders.
Participants in this open-label study will be randomly assigned to the Incredible Years
training program or a waitlist condition, in which they will begin the program after a
1-year waiting period. Parent training sessions will take place once per week for 10 weeks,
and will last approximately 2 hours each. Sessions will focus on teaching positive parenting
skills, such as appropriate play and use of praise and rewards, as well as limit-setting
techniques, such as ignoring, allowing children to experience the natural consequences of
their actions, and assigning time-outs. Self-report assessments and phone interviews will be
used to assess outcomes. Additionally, follow-up visits will occur immediately
post-intervention and 6 and 12 months post-intervention. Children will attend one visit
before the program begins, as well as the follow-ups held immediately post-intervention and
12 months post-intervention. These visits will include videotaped observations of children
and their primary caregivers.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00381407 -
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 |